Gray Fleming - 30 Nov 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship: Chief Commercial Officer
Issuer ticker: BSGM
Reported as of: 30 Nov 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Dec 2023, 19:01:39 UTC
Prior SEC filing: 09 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Gray Fleming

Key filing fact

Gray Fleming filed Form 4 for BioSig Technologies, Inc. (BSGM) on 04 Dec 2023.

Key facts

This page summarizes Gray Fleming's Form 4 filing for BioSig Technologies, Inc. (BSGM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Dec 2023, 19:01.

Change

Previous filing in this sequence was filed on 09 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

This filing has been restated. Open the amended filing.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSGM transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +131,900
Change %
Price: $0.000000
Shares after: 131,900
Date: 30 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 131,900
Exercise price: $0.2603
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This stock option fully vested on November 30, 2023, the date of grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.